NCT01859962 Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C Status COMPLETED Phase PHASE2
NCT01858961 Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients Status WITHDRAWN Phase PHASE3
NCT01856478 LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy Status COMPLETED Phase PHASE3
NCT01853839 Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients Status COMPLETED Phase N/A
NCT01853826 An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s) Status COMPLETED Phase PHASE3
NCT01845077 Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets Status COMPLETED Phase PHASE1
NCT01844531 Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets Status COMPLETED Phase PHASE1
NCT01843972 Safety of Single Rising Doses and Relative Bioavailability of BI 691751 Status COMPLETED Phase PHASE1
NCT01841112 Safety, Tolerability and Pharmacokinetics of BI 409306 Tablets in Healthy Asian Male Volunteers Status COMPLETED Phase PHASE1
NCT01836341 Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation Status WITHDRAWN Phase PHASE1
NCT01835899 Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1015550 Powder for Oral Solution Status COMPLETED Phase PHASE1
NCT01830127 BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3 Status COMPLETED Phase PHASE2
NCT01826370 Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus Status TERMINATED Phase N/A
NCT01811953 Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered Together Status COMPLETED Phase PHASE1
NCT01809262 Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE2